Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,336 total articles
CorMedix Therapeutics announced that its management team will participate in investor conferences hosted by RBC Capital Markets and Jefferies in May and June 2026, where they will engage in fireside chats and investor meetings to discuss the company's developments and strategies in the biopharmaceutical sector focused on life-threatening conditions…
Data Storage Corporation announced the establishment of Sovereign AI Solutions (SaiS), a new subsidiary focused on AI continuity infrastructure for regulated industries including healthcare, financial services, and insurance. The company reported a 10.9% year-over-year increase in Nexxis sales and a 32.1% rise in gross profit, highlighting strong d…
Jyong Biotech Ltd., a Taiwan-based biotechnology company specializing in plant-derived therapeutics, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The report, which includes audited consolidated financial statements, is now accessible via the com…
Moleculin Biotech announced first quarter 2026 financial results alongside promising clinical updates for its pivotal MIRACLE Phase 3 trial evaluating Annamycin combined with cytarabine in difficult-to-treat relapsed or refractory acute myeloid leukemia (AML) patients. Early blinded data from 45 patients showed a 40% composite complete remission ra…
SRx Health Solutions announced that its board has approved a dividend distribution of 75% of profits from its investment in Astro Investment XVII, an affiliate of Astro Capital. This investment includes holdings in SpaceX and other artificial intelligence and space technology companies. The move reflects SRx Health Solutions' confidence in the long…
Bath & Body Works, Inc. has declared a regular quarterly cash dividend of $0.20 per share, payable on June 19, 2026 to shareholders of record as of June 5, 2026. The company highlights its strong brand presence in personal care and fragrance products through extensive retail and online operations.
BTCS Inc., an Ethereum-first blockchain technology company, reported Q1 2026 financial results showing a 27% year-over-year revenue increase to $2.1 million and a 745% rise in gross profit to $1.0 million with a 47% gross margin. The growth was mainly driven by the Imperium DeFi revenues, which represent nearly half of total revenue. Despite a net …
Wrap Technologies announced that William Paterson University has purchased its WrapReality virtual reality training system to enhance the university's Criminology and Criminal Justice Program. This acquisition supports immersive learning for students and aligns with Wrap's strategy to expand its VR training platform beyond traditional law enforceme…
Silexion Therapeutics Corp., a clinical-stage biotech focused on RNA interference therapies for KRAS-driven cancers, announced the exercise of warrants to raise approximately $1 million. The funds will be used as working capital to advance clinical trials, including their lead siRNA candidate SIL204 targeting locally advanced pancreatic cancer. The…
Nordic American Tankers Ltd announced several recently concluded shipping contracts with large companies, generating daily rates between $75,000 and $198,000 over various periods. Operating costs remain below $10,000 per day, which supports a robust cash position enhancing their ability to pay dividends. The contracts span from March through May, i…
Jiuzi Holdings, Inc., through its subsidiary Jiuzi New York Inc., has signed a strategic Memorandum of Understanding with a top-tier AI technology company to collaboratively develop advanced AI-driven imaging platforms, cloud infrastructure, and scalable data management solutions. This partnership aims to enhance AI analytics capabilities across va…
Obagi Medical, part of Waldencast plc (NASDAQ: WALD), disclosed encouraging interim clinical and real-world data for its new skincare innovations: the NU-GEN Cellular Renewal Serum and Saypha® MagIQ™ injectable filler, presented at the Music City Symposium for Cosmetic Advances & Laser Education (SCALE). Data from over 300 clinical sites validate t…
Safe Pro Group Inc. (NASDAQ: SPAI) announced exceptional first quarter 2026 financial results with record revenue of $1.22 million, a 560% increase from the prior year, driven by a 2,400% surge in AI-powered product sales. The company’s AI solutions, including the NODE and NODE-X edge processing systems and the SPOTD threat detection platform, demo…
INmune Bio released Phase 2 MINDFuL trial results demonstrating positive trends for XPro™ (pegipanermin) in Alzheimer's patients with inflammatory biomarkers. The findings, published in NPJ Dementia, showed consistent benefit across multiple clinical and biomarker endpoints with no amyloid-related imaging abnormalities, validating the inflammation-…
CG Oncology reported positive interim results from its Phase 2 CORE-008 Cohort CX trial evaluating the combination of cretostimogene grenadenorepvec with gemcitabine in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are BCG-exposed or BCG-unresponsive. The study showed high complete response rates, strong high-grade event-fr…
aTyr Pharma announced its Q1 2026 financial results and outlined a clear regulatory path forward for efzofitimod in pulmonary sarcoidosis. Following a Type C FDA meeting, the company plans to submit an IND in June 2026 for a global Phase 3 trial targeting patients with chronic pulmonary sarcoidosis and restrictive lung disease. Enrollment is on tra…
Cocrystal Pharma has completed enrollment in the first cohort of its Phase 1b human challenge study for CDI-988, an oral protease inhibitor targeting norovirus and coronaviruses. The company received FDA Fast Track designation for CDI-988, enabling potential accelerated development. Additionally, it secured the initial $225,000 SBIR NIH grant for i…
Dycom Industries, Inc., a leading specialty contracting service provider in telecommunications and utilities, announced it will hold its fiscal 2027 first quarter earnings call on May 27, 2026. A press release with the quarter's financial results will be issued earlier that day, followed by a conference call and webcast to discuss performance and a…
Perma-Fix Environmental Services, Inc. announced it has priced an underwritten public offering of approximately 2.29 million shares of common stock at $8.75 per share to raise gross proceeds of about $20 million. The company plans to use the net proceeds to fund capacity upgrades at its Northwest Richland facility, continue research and development…
UroGen Pharma reported that its investigational drug UGN-103 achieved a 94.5% six-month durability of response in the ongoing Phase 3 UTOPIA trial for patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). The results align closely with the performance of ZUSDURI, the company's FDA-approved treatment i…
LifeMD, Inc., a leading virtual primary care platform, announced that its management will participate in the LD Micro Invitational XVI Conference and the B. Riley Securities 26th Annual Investor Conference in May 2026. The company aims to engage with investors through presentations and one-on-one meetings to discuss its telemedicine offerings and g…
BioCardia, Inc. reported Q1 2026 financial results and highlighted regulatory progress for its CardiAMP Cell Therapy in ischemic heart failure. PMDA in Japan acknowledged sufficient safety and efficacy evidence for market clearance, moving the therapy closer to approval. The FDA expressed support for continuing the CardiAMP HF II confirmatory trial…
Our Bond, Inc., an AI-powered preventative personal security platform company, provided a business update and reported Q1 2026 financial results with modest revenue growth of 4.36% to $2.3 million. The company expanded its global footprint and enterprise deployments across varied sectors including retail, telecommunications, financial services, and…
Trio Petroleum Corp. is reminding shareholders to vote in advance of its May 21, 2026 Annual Meeting. The company emphasizes the importance of achieving quorum to approve proposals that facilitate its strategy of disciplined expansion through acquisitions and operational execution. Trio highlights its improved financial position and focus on long-t…
LanzaTech Global, Inc. announced a registered direct offering of 2 million common stock shares to institutional investors, aiming to raise approximately $20 million before expenses. The proceeds will be used for general corporate purposes. The offering is expected to close around May 18, 2026, under an SEC-approved shelf registration. LanzaTech spe…
